| Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease M Lundblad, M Andersson, C Winkler, D Kirik, N Wierup, MA Cenci European Journal of Neuroscience 15 (1), 120-132, 2002 | 776 | 2002 |
| TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity M Decressac, B Mattsson, P Weikop, M Lundblad, J Jakobsson, ... Proceedings of the National Academy of Sciences 110 (19), E1817-E1826, 2013 | 773 | 2013 |
| Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions A Kirkeby, S Grealish, DA Wolf, J Nelander, J Wood, M Lundblad, ... Cell reports 1 (6), 703-714, 2012 | 738 | 2012 |
| Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons M Lundblad, M Decressac, B Mattsson, A Björklund Proceedings of the National Academy of Sciences 109 (9), 3213-3219, 2012 | 370 | 2012 |
| A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function M Lundblad, B Picconi, H Lindgren, MA Cenci Neurobiology of disease 16 (1), 110-123, 2004 | 369 | 2004 |
| Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons M Decressac, B Mattsson, M Lundblad, P Weikop, A Björklund Neurobiology of disease 45 (3), 939-953, 2012 | 334 | 2012 |
| Ratings of L‐DOPA‐Induced Dyskinesia in the Unilateral 6‐OHDA Lesion Model of Parkinson's Disease in Rats and Mice MA Cenci, M Lundblad Current protocols in Neuroscience 41 (1), 9.25. 1-9.25. 23, 2007 | 306 | 2007 |
| Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model A Dekundy, M Lundblad, W Danysz, MA Cenci Behavioural brain research 179 (1), 76-89, 2007 | 269 | 2007 |
| Post‐versus presynaptic plasticity in L‐DOPA‐induced dyskinesia MA Cenci, M Lundblad Journal of neurochemistry 99 (2), 381-392, 2006 | 256 | 2006 |
| Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia M Lundblad, A Usiello, M Carta, K Håkansson, G Fisone, MA Cenci Experimental neurology 194 (1), 66-75, 2005 | 226 | 2005 |
| Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain P Thakur, LS Breger, M Lundblad, OW Wan, B Mattsson, KC Luk, ... Proceedings of the National Academy of Sciences 114 (39), E8284-E8293, 2017 | 216 | 2017 |
| Cellular and behavioural effects of the adenosine A2a receptor antagonist KW‐6002 in a rat model of l‐DOPA‐induced dyskinesia M Lundblad, E Vaudano, MA Cenci Journal of neurochemistry 84 (6), 1398-1410, 2003 | 192 | 2003 |
| Role of striatal l‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats M Carta, HS Lindgren, M Lundblad, R Stancampiano, F Fadda, MA Cenci Journal of neurochemistry 96 (6), 1718-1727, 2006 | 182 | 2006 |
| Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia C Konradi, JE Westin, M Carta, ME Eaton, K Kuter, A Dekundy, ... Neurobiology of disease 17 (2), 219-236, 2004 | 174 | 2004 |
| Persistent changes in striatal gene expression induced by long‐term l‐DOPA treatment in a rat model of Parkinson's disease JE Westin, M Andersson, M Lundblad, MA Cenci European journal of neuroscience 14 (7), 1171-1176, 2001 | 160 | 2001 |
| VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation C Birgner, K Nordenankar, M Lundblad, JA Mendez, C Smith, M le Grevès, ... Proceedings of the National Academy of Sciences 107 (1), 389-394, 2010 | 139 | 2010 |
| The “motor complication syndrome” in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration HS Lindgren, D Rylander, KE Ohlin, M Lundblad, MA Cenci Behavioural brain research 177 (1), 150-159, 2007 | 134 | 2007 |
| Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia T Carlsson, C Winkler, M Lundblad, MA Cenci, A Björklund, D Kirik Neurobiology of disease 21 (3), 657-668, 2006 | 126 | 2006 |
| Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease U Nordström, G Beauvais, A Ghosh, BCP Sasidharan, M Lundblad, ... Neurobiology of disease 73, 70-82, 2015 | 92 | 2015 |
| A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP C Hansen, T Björklund, GH Petit, M Lundblad, RP Murmu, P Brundin, ... Neurobiology of disease 56, 145-155, 2013 | 74 | 2013 |
Anders BjörklundLund University, SwedenVerified email at med.lu.se
